Development of the first potential covalent inhibitors of anandamide cellular uptake

Aniello Schiano Moriello, Laurence Balas, Alessia Ligresti, Maria Grazia Cascio, Thierry Durand, Enrico Morera, Giorgio Ortar, Vincenzo Di Marzo*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

On the basis of the chemical structures of two previously developed metabolically stable and relatively potent inhibitors of anandamide uptake, OMDM-1,2, two series of potential covalent inhibitors of anandamide cellular reuptake, which might be used for the molecular characterization of the protein(s) involved in the membrane transport of endocannabinoids, have been designed and synthesized. Most of the compounds inhibited uptake to a varied extent and in a generally enantio-sensitive manner when co-incubated with [ 14C]anandamide, but only three of them, the photoactivatable 1a (OMDM-37), 1b (OMDM-39), and 8 (Lo395), also produced a significant inhibition of uptake following the preincubation only of the cells, and this effect was significantly enhanced following UV exposure only in the case of 8. None of the new compounds inhibited [14C]anandamide hydrolysis with IC 50 < 50 μM, except for 1b.

Original languageEnglish
Pages (from-to)2320-2332
Number of pages13
JournalJournal of Medicinal Chemistry
Volume49
Issue number7
Early online date4 Mar 2006
DOIs
Publication statusPublished - 1 Apr 2006

Fingerprint

Dive into the research topics of 'Development of the first potential covalent inhibitors of anandamide cellular uptake'. Together they form a unique fingerprint.

Cite this